Generic drug maker enters January IPO pipeline

Hindustan Laboratories has filed draft papers for an IPO comprising a fresh issue of 50 lakh shares and an offer for sale of 91 lakh shares. The pharmaceutical company focuses on generic formulations. Proceeds are expected to support working capital requirements as domestic healthcare demand remains steady and export opportunities continue to develop across regulated and semi regulated markets.